ABVC BioPharma Inc.

NASDAQ: ABVC · Real-Time Price · USD
2.87
-0.26 (-8.31%)
At close: Aug 19, 2025, 3:59 PM
2.91
1.39%
After-hours: Aug 19, 2025, 07:18 PM EDT

ABVC BioPharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.4 -0.65 -1.2 -6.61
PEG Ratio
0.02 0.01 -0.61 -2.53
PS Ratio
13.52 33.00 20.40 238.67
PB Ratio
5.62 0.60 6.39 9.60
P/FCF Ratio
-3.81 -1.18 -2.63 -11.15
P/OCF Ratio
-3.81 -1.19 -2.67 -11.18
OCF/S Ratio
-3.55 -27.79 -7.63 -21.35
Debt / Equity Ratio
2.61 0.27 0.99 0.35
Quick Ratio
0.33 0.28 0.30 2.60
Current Ratio
0.33 0.28 0.54 2.61
Asset Turnover
0.07 0.01 0.10 0.03
Interest Coverage
-5.7 -5.15 -51.41 -51.52
Return on Equity
-4 -0.93 -5.3 -1.45
Return on Assets
-0.65 -0.54 -1.67 -0.94
Return on Invested Capital
-1.17 -0.67 -2.42 -1.05
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -0.98 0.70 0.99
Net Profit Margin
-9.62 -51.09 -16.93 -36.09
Pretax Profit Margin
-10.54 -52.65 -16 -31.51
Operating Profit Margin
-9.23 -44.39 -15.58 -32.9
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-8.52 -41.53 -15.67 -30.84